Brief: ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections
20/05/2025 11:08
May 20 (Reuters) - Innoviva Inc INVA.O: ZEVTERA® (CEFTOBIPROLE), AN ADVANCED-GENERATION CEPHALOSPORIN ANTIBIOTIC NOW COMMERCIALLY AVAILABLE IN THE U.S. TO TREAT THREE TYPES OF BACTERIAL INFECTIONS Source text: ID:nBw1PK348a Further company coverage: INVA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million